Webinars • Breast Cancer Foundation NZ

Podcasts & Videos

Loading

Hormone receptor-positive (ER+/PR+) breast cancer

Hormone receptor-positive breast cancer

About 80 percent of all breast cancers in New Zealand are hormone receptor-positive.

Hormone receptors are proteins found on breast cells.

They pick up the estrogen or progesterone signals that promote cell growth; including cancer cell growth if they contain the receptors for these hormones. Breast cancer cells with receptors for either hormone are considered hormone receptor-positive (HR+).

Breast tumours may be positive for estrogen receptors (ER+), progesterone receptors (PR+) or both (ER/PR+). 

Our expert panel share their experiences with HR+ breast cancer from a patient and clinical perspective.